Weinshenker B - Search Results

1

Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.

Frohman EM, Stüve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, Sorensen PS, Phillips JT, Weinshenker B, Hawker K, Hartung HP, Steinman L, Zamvil S, Cree BA, Hauser S, Weiner H, Racke MK, Filippi M. Frohman EM, et al. Among authors: weinshenker b. Arch Neurol. 2005 Oct;62(10):1519-30. doi: 10.1001/archneur.62.10.1519. Arch Neurol. 2005. PMID: 16216934 Review.

2

A comparison of sporadic and familial multiple sclerosis.

Weinshenker BG, Bulman D, Carriere W, Baskerville J, Ebers GC. Weinshenker BG, et al. Neurology. 1990 Sep;40(9):1354-8. doi: 10.1212/wnl.40.9.1354. Neurology. 1990. PMID: 2392217

3

Systemic interferon alfa in multiple sclerosis.

Weinshenker BG, Ebers GC. Weinshenker BG, et al. Arch Neurol. 1989 Mar;46(3):251-2. doi: 10.1001/archneur.1989.00520390017007. Arch Neurol. 1989. PMID: 2919976 No abstract available.

4

Long-term and short-term outcome of multiple sclerosis: a 3-year follow-up study.

Weinshenker BG, Issa M, Baskerville J. Weinshenker BG, et al. Arch Neurol. 1996 Apr;53(4):353-8. doi: 10.1001/archneur.1996.00550040093018. Arch Neurol. 1996. PMID: 8929158

5

The natural history of multiple sclerosis: implications for trial design.

Wingerchuk DM, Weinshenker BG. Wingerchuk DM, et al. Among authors: weinshenker bg. Curr Opin Neurol. 1999 Jun;12(3):345-9. doi: 10.1097/00019052-199906000-00013. Curr Opin Neurol. 1999. PMID: 10499179 Review.

6

A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.

Wingerchuk DM, Benarroch EE, O'Brien PC, Keegan BM, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M. Wingerchuk DM, et al. Among authors: weinshenker bg. Neurology. 2005 Apr 12;64(7):1267-9. doi: 10.1212/01.WNL.0000156803.23698.9A. Neurology. 2005. PMID: 15824361 Clinical Trial.

7

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Polman CH, et al. Ann Neurol. 2005 Dec;58(6):840-6. doi: 10.1002/ana.20703. Ann Neurol. 2005. PMID: 16283615 Review.

8

Not every patient with multiple sclerosis should be treated at time of diagnosis.

Pittock SJ, Weinshenker BG, Noseworthy JH, Lucchinetti CF, Keegan M, Wingerchuk DM, Carter J, Shuster E, Rodriguez M. Pittock SJ, et al. Arch Neurol. 2006 Apr;63(4):611-4. doi: 10.1001/archneur.63.4.611. Arch Neurol. 2006. PMID: 16606780 No abstract available.

9

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.

Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Pittock SJ, et al. Arch Neurol. 2006 Jul;63(7):964-8. doi: 10.1001/archneur.63.7.964. Arch Neurol. 2006. PMID: 16831965

10

Men transmit MS more often to their children vs women: the Carter effect.

Kantarci OH, Barcellos LF, Atkinson EJ, Ramsay PP, Lincoln R, Achenbach SJ, De Andrade M, Hauser SL, Weinshenker BG. Kantarci OH, et al. Among authors: weinshenker bg. Neurology. 2006 Jul 25;67(2):305-10. doi: 10.1212/01.wnl.0000225070.13682.11. Neurology. 2006. PMID: 16864824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters